HSBC Holdings
EDIT icon

HSBC Holdings’s Editas Medicine EDIT Stock Holding History

HSBC Holdings’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$274K Hold
112,186
– – ﹤0.01% 2486
2025
Q4 		$231K Buy
112,186
+16,288
+17% +$47K ﹤0.01% 2636
2025
Q3 		$326K Buy
95,898
+42,870
+81% +$120K ﹤0.01% 2298
2025
Q2 		$122K Sell
53,028
-5,285
-9% -$8.65K ﹤0.01% 2808
2025
Q1 		$67.4K Sell
58,313
-63
-0.1% -$93 ﹤0.01% 2870
2024
Q4 		$72.4K Buy
58,376
+1,725
+3% +$4.39K ﹤0.01% 2944
2024
Q3 		$197K Sell
56,651
-48,143
-46% -$210K ﹤0.01% 2619
2024
Q2 		$488K Buy
104,794
+62,561
+148% +$353K ﹤0.01% 1978
2024
Q1 		$313K Buy
42,233
+10,696
+34% +$88.9K ﹤0.01% 2421
2023
Q4 		$323K Buy
31,537
+302
+1% +$2.65K ﹤0.01% 2244
2023
Q3 		$240K Buy
31,235
+18,602
+147% +$160K ﹤0.01% 2330
2023
Q2 		$104K Sell
12,633
-1,660
-12% -$14.5K ﹤0.01% 2423
2023
Q1 		$104K Buy
+14,293
New +$127K ﹤0.01% 2503
2020
Q4 		– Sell
-13,178
Closed -$374K – 3059
2020
Q3 		$374K Buy
+13,178
New +$429K ﹤0.01% 2115

Other funds holding EDIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

HSBC Holdings's EDIT Position: Q1 2026 in Review

HSBC Holdings held its Editas Medicine (EDIT) position steady in Q1 2026 at 112,186 shares worth $274K. The position accounts for ﹤0.01% of the portfolio, ranked #2486.

HSBC Holdings first reported a position in EDIT in Q3 2020 and has held it in 14 quarters since. The position peaked at $488K in Q2 2024. 208 funds tracked by Wall St. Rank hold EDIT as of Q1 2026.

  • HSBC Holdings held 112,186 shares of Editas Medicine worth $274K as of Q1 2026.
  • HSBC Holdings left its Editas Medicine share count unchanged in Q1 2026.
  • Editas Medicine made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #2486 holding.
  • HSBC Holdings first reported a position in Editas Medicine in Q3 2020 and has held it in 14 quarters since.
  • HSBC Holdings's Editas Medicine position peaked at $488K in Q2 2024.
  • 208 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.